DTA Home 2018-10-16T00:21:00+00:00

Digital Therapeutics Alliance

Improving healthcare quality, outcomes, and value through optimizing the use and integration of digital therapeutic solutions

Learn More

What are Digital Therapeutics?

Digital therapeutics (DTx) deliver evidence-based therapeutic interventions to patients that are driven by high quality software programs to prevent, manage, or treat a medical disorder or disease. They are used independently or in concert with medications, devices, or other therapies to optimize patient care and health outcomes.

DTx products incorporate advanced technology best practices relating to design, clinical validation, usability, and data security, and are validated by regulatory bodies as required to support product claims regarding risk, efficacy, and intended use.

Digital therapeutics empower patients, healthcare providers, and payers with intelligent and accessible tools for addressing a wide range of conditions through high quality, safe, and effective data-driven interventions.

LEARN MORE

Digital Therapeutics Alliance

Founded in 2017, the Digital Therapeutics Alliance (DTA) is a global non-profit trade association of industry leaders and stakeholders engaged in the evidence-driven advancement of digital therapeutics. DTA maintains an international industry focus and is headquartered in the United States.

DTA exists to broaden the understanding, adoption, and integration of clinically-validated digital therapeutics into healthcare through education, advocacy, and research. DTA works to enable expanded access to high quality, evidence-based digital therapeutics for patients, healthcare providers, and payers in order to improve clinical and health economic outcomes.

Learn more

DTA News

Digital Therapeutics Alliance boosts European presence

DUBLIN, IRELAND, 16 October 2018 /S3 Connected Health News/ > Digital Therapeutics Alliance (DTA) boosts Europe presence to advance the adoption of evidence-based digital therapeutics > S3 Connected Health, a DTA member, is working alongside fellow EU-based members to lead [...]

Digital Therapeutics Alliance and USP Announce Collaboration

WASHINGTON, June 4, 2018 /PRNewswire-USNewswire/ – The Digital Therapeutics Alliance (DTA) and USP announced a collaboration to explore the development of appropriate standards and guidelines for digital therapeutics at a roundtable discussion co-hosted by the two organizations today at USP [...]

The Digital Therapeutics Alliance Announces New Members

Arlington, VA — May 8, 2018 — The Digital Therapeutics Alliance welcomes nine companies to membership: Bayer, Big Health, Cognoa, Kaia Health, Merck, Omada Health, Otsuka America Pharmaceutical, Inc., Pear Therapeutics, and Sanofi. “Digital medicine has the potential to safely and effectively [...]

Read More

Stay in Touch

SIGN UP FOR DTA UPDATES & LEARN ABOUT MEMBERSHIP

Get Connected